This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Newell's Q1 Loss Narrower Than Expected, Core Sales Down 2.1%
by Zacks Equity Research
NWL reports a sales decline in first-quarter 2025, owing to a core sales drop of 2.1% year over year.
Here's How Colgate is Poised Post Q1 Earnings: Buy or Hold the Stock?
by Zacks Equity Research
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
MO Q1 Earnings Beat Estimates, Sales Decline on Low Cigarette Volumes
by Zacks Equity Research
Altria's Q1 results reflect increased earnings on higher operating income. Management expects earnings growth in 2025.
Kraft Heinz's Q1 Earnings Beat Estimates, 2025 View Lowered
by Zacks Equity Research
KHC's first-quarter sales meet the Zacks Consensus Estimate, while organic net sales decline 4.7% amid volume/mix pressures.
TAP's Innovations on Track: Topo Chico Hard Debuts Margarita Beverages
by Zacks Equity Research
Molson Coors is focused on portfolio premiumization and innovations. Topo Chico Hard Seltzer is extending its portfolio into flavored alcoholic beverages.
Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y
by Zacks Equity Research
MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.
BellRing Brands (BRBR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
BellRing Brands (BRBR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate Q1 Earnings & Sales Beat Estimates, Organic Sales Rise 1.4%
by Zacks Equity Research
CL posts better-than-expected first-quarter 2025 results. Results benefited from organic sales growth, robust volume and pricing performance.
Helen of Troy Shares Down on Q4 Earnings Miss, Sales Decline Y/Y
by Zacks Equity Research
HELE's fiscal fourth-quarter results reflect a 0.7% sales dip, due to a 4.9% decline in organic business sales.
Procter & Gamble Meet Earnings Estimates in Q3, Organic Sales Up 1% Y/Y
by Zacks Equity Research
PG matches earnings estimates in third-quarter fiscal 2025, while sales remain soft. Organic sales grew year over year, driven by the rise in pricing.
Utz Brands (UTZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Utz Brands (UTZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Philip Morris Q1 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
PM's first-quarter 2025 results reflect increased earnings and sales on robust momentum across all regions.
Kimberly-Clark's Q1 Earnings Top Estimates, Organic Sales Down 1.6%
by Zacks Equity Research
KMB's first quarter sales dip 6%, with organic sales declining 1.6%. Management updates 2025 outlook amid cost pressures and global headwinds.
3 Miscellaneous Food Stocks to Buy Despite Prevailing Industry Setbacks
by Nalak Das
Three miscellaneous food stocks have strong short-term price upside potentials. These are: CELH, UNFI, UTZ.
Should You Buy Dollar General Stock at Its Current Valuation?
by Zacks Equity Research
Dollar General is trading well below its industry peers, but is this a golden buying opportunity? Here's what investors need to know before jumping in.
POST Stock Trades Above 50 & 200-Day SMA: What Should Investors Do?
by Zacks Equity Research
Post Holdings drives growth through acquisitions and pricing strength, while tackling cost pressures and soft volumes in key segments.
Should You Buy Central Garden and Pet Stock at its Current Valuation?
by Zacks Equity Research
CENT is driving growth through innovation, operational efficiency and strong earnings momentum, positioning itself for continued success.
UTZ vs. MDLZ: Which Stock Is the Better Value Option?
by Zacks Equity Research
UTZ vs. MDLZ: Which Stock Is the Better Value Option?
Ollie's Bargain Stock Up 11% in a Month: Lock in Gains or Hold?
by Zacks Equity Research
Ollie's Bargain has posted strong growth with solid expansion plans. But with its high valuation, is the stock still a buy?
GIS Stock Plunges More Than 18% in 6 Months: What Should You Do?
by Zacks Equity Research
General Mills is facing challenges like inflation, shifting consumer preferences and intensified competition.
Medifast Trades Near 52-Week Low: What's the Best Move Now?
by Zacks Equity Research
MED faces steep revenue declines and coach losses but aims to rebound through innovation, marketing and new GLP-1-focused initiatives.
Grocery Outlet Up 10% in a Month: Is the Stock Still a Good Buy?
by Zacks Equity Research
GO is focused on long-term growth, leveraging the unique model while navigating challenges and positioning itself for success in a competitive market.
BJ's Wholesale Reaches 52-Week High: Should You Hold or Cash Out Now?
by Zacks Equity Research
BJ's Wholesale stock is soaring, but after a 34% YTD rally, should you ride the momentum or lock in gains?
Molson Coors Up 13.1% in 6 Months: Buy, Hold or Avoid the Stock?
by Zacks Equity Research
TAP makes significant progress with the Acceleration Plan. It is focused on portfolio premiumization as well.
UNFI Stock Gains 150.4% in a Year: What's Next for Investors?
by Zacks Equity Research
United Natural is boosting growth through cost discipline, network optimization and strong earnings performance, setting the stage for continued success.